245 related articles for article (PubMed ID: 9416841)
1. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
2. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
[TBL] [Abstract][Full Text] [Related]
3. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
[TBL] [Abstract][Full Text] [Related]
4. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
[TBL] [Abstract][Full Text] [Related]
5. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
[TBL] [Abstract][Full Text] [Related]
6. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
[TBL] [Abstract][Full Text] [Related]
7. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
8. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
9. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
11. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors.
Klinger MB; Guilbault B; Goulding RE; Kay RJ
Oncogene; 2005 Apr; 24(16):2695-704. PubMed ID: 15829980
[TBL] [Abstract][Full Text] [Related]
12. Bax accelerates tumorigenesis in p53-deficient mice.
Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ
Cancer Res; 2001 Jan; 61(2):659-65. PubMed ID: 11212265
[TBL] [Abstract][Full Text] [Related]
13. Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis.
Mangues R; Symmans WF; Lu S; Schwartz S; Pellicer A
Oncogene; 1996 Sep; 13(5):1053-63. PubMed ID: 8806695
[TBL] [Abstract][Full Text] [Related]
14. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
Reese JS; Allay E; Gerson SL
Oncogene; 2001 Aug; 20(38):5258-63. PubMed ID: 11536039
[TBL] [Abstract][Full Text] [Related]
16. Oncogene-induced senescence as an initial barrier in lymphoma development.
Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
[TBL] [Abstract][Full Text] [Related]
17. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
18. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
[TBL] [Abstract][Full Text] [Related]
19. CD2 promoter regulated nucleophosmin-anaplastic lymphoma kinase in transgenic mice causes B lymphoid malignancy.
Turner SD; Merz H; Yeung D; Alexander DR
Anticancer Res; 2006; 26(5A):3275-9. PubMed ID: 17094440
[TBL] [Abstract][Full Text] [Related]
20. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A
Cancer Res; 1991 Feb; 51(3):958-63. PubMed ID: 1988138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
